TruthArchive.ai - Related Video Feed

The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world. They claim drug companies have tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. Despite this, the speaker says they don't care and must do what's right.

The speaker claims that the Rockefellers control major drug companies worldwide, with their representatives in top positions. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current allopathic system of medicine in the US. Healthcare costs have skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people.

Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the current system was fair, even though the reasons why were not widely understood.

Pharmaceutical companies claimed research and development costs had to be borne by America alone, which effectively meant American patients were subsidizing socialist healthcare systems in places like Germany and the European Union. The speaker believes the European Union is nastier than China and has treated the U.S. unfairly. However, the speaker asserts that the U.S. now holds all the cards and expects the European Union to concede.

The U.S. spends $1,126 per capita on drugs, while Britain spends about $240, roughly one-fifth of the U.S. amount, a trend seen across Europe. Drug companies claim America must pay for innovation. President Trump argues that European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. will no longer subsidize them. If Europeans raise drug prices by 20%, $10 trillion could be spent on innovation, improving global health through better products.

Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the existing system was fair, even though the reasons why were not well understood. The speaker claims to have figured out the reasons behind this.

Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

Robert F. Kennedy Jr. praises President Trump for addressing the discrepancy between US and European drug prices, a promise unfulfilled by previous Democratic leaders due to pharmaceutical industry influence. Kennedy claims there is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member, and the industry spends three times more on lobbying than any other. Kennedy states that Trump cannot be bought and is standing up to oligarchs, unlike other politicians. He notes that the US, with 4.2% of the world's population, accounts for 75% of pharmaceutical company revenues, spending $11.26 per capita on drugs compared to Britain's $240. Kennedy says Trump is asking European partners to increase their drug payments to fund innovation, suggesting a 20% increase would free up $10 trillion for innovation and improve global health.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world with tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. The speaker claims they don't care and have to do what's right.

American patients were subsidizing socialist healthcare systems in the European Union. The European Union is nastier than China, but they will come down a lot. The U.S. has all the cards because the EU treated the U.S. unfairly. The EU sells the U.S. 13 million cars, but the U.S. sells them none. The EU sells the U.S. their agricultural products, but they don't take U.S. products. Because of this unfairness, the EU will have to pay more for healthcare, and the U.S. will have to pay less.

The speaker states that the U.S. will tariff pharmaceuticals. They believe this will cause pharmaceutical companies to move back to the U.S. because the U.S. is the biggest market. The speaker asserts that the U.S.'s advantage is being the biggest market. They say a major tariff on pharmaceuticals will be announced shortly. The speaker believes that upon hearing this, pharmaceutical companies will leave China and other places because most of their product is sold in the U.S.

The speaker states that countries represented by the European Union will be told "that game is up." If they "get cute," they won't be able to sell cars into the United States anymore. The speaker claims that European unions and other countries gave drug companies a price, expecting America to pay the difference to cover a shortfall. The speaker says "that's what we did, but we're not doing it anymore."

The speaker states that countries represented by the European Union will be told "that game is up." If they "get cute," they won't be able to sell cars into the United States anymore. The speaker claims that European Union countries gave drug companies a price, expecting America to pay the difference to cover a shortfall. The speaker says "that's what we did, but we're not doing it anymore."

The speaker claims that the Rockefellers control major drug companies worldwide, with their representatives in top positions. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current allopathic system of medicine in the US. Healthcare costs have skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people.

The speaker claims that the Rockefellers control major drug companies through their influence on directors and officials. They aim to control all aspects of biology, including hormones, glands, and genes, as part of their goal of social control and eugenics. Since 1910, John D. Rockefeller has dominated the medical industry in the US, controlling hospitals, physicians, and medications. This has led to skyrocketing healthcare costs, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with an average cost of $120,000. Despite the high costs and limited effectiveness, doctors still recommend treatments that cause pain and suffering, ultimately benefiting financially from patients. These monopolies are interconnected and controlled by a group of elitists known as the world order people.

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

Americans pay significantly more for prescription drugs than other countries, sometimes up to 10 times more. Pharmaceutical companies generate two-thirds of their profits in the U.S., effectively making Americans subsidize healthcare in other countries. The administration is introducing a "most favored nation" pricing model, ensuring the U.S. pays the lowest price available globally for drugs. For example, a breast cancer drug costing over $16,000 in the U.S. is a fraction of that price in Australia and Sweden. Similarly, an asthma drug costs almost $500 in the U.S. but less than $40 in the UK. The plan involves directing investigations into foreign nations that block drug products unless they accept low prices, and the U.S. will defend drug companies from unfair pricing demands. The administration aims to cut out middlemen and facilitate direct drug sales at the most favored nation price. If companies don't comply, the U.S. will use its trade powers and open the market to safe, legal drug imports.

Healthcare companies will likely make the same amount of money because it's a redistribution of wealth across the world, not just the European Union. Europe and the rest of the world will pay a little more, while America will pay a lot less. This is due to America having a smaller population compared to the entire world. The top line for healthcare companies could remain the same, but it will be distributed differently.

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. This issue was considered radioactive, but President Trump addressed it despite past contributions from pharmaceutical companies, which may have totaled $100,000,000. Unlike other politicians, Trump cannot be bought and is standing up for the American people. Despite claims from figures like Elizabeth Warren and Robert Reich that President Trump is on the side of the oligarchs, no president has been more willing to stand up to them than President Donald Trump. The speaker expressed pride in the President's courage and willingness to stand up for the American people.

The speaker claims that the Rockefellers control major drug companies worldwide, with their representatives in top positions. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current allopathic system of medicine in the US. Healthcare costs have skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people.

The speaker claims that the Rockefellers control major drug companies worldwide, with their representatives in top positions. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current allopathic system of medicine in the US. Healthcare costs have skyrocketed, making it unaffordable for most Americans. Cancer treatment is particularly expensive, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people. (134 words)